Vyome narrows Q3 loss to $0.13 per share, cash rises to $7M
Vyome Holdings (NASDAQ:HIND) reported a narrower Q3 loss of $0.13 per share, down from $3.06 a year ago. Revenue increased to $57,998 from $34,627, but nine-month revenue fell to $116,544. Cash rose to $6.96M. Operating expenses decreased to $1.05M. The company is developing VT-1953 and appointed a new CFO. The FDA requested more info on its orphan drug designation.
